Used primarily as a key intermediate in the synthesis of antifungal agents, particularly in the production of triazole-based pharmaceuticals. Its structure supports strong interaction with fungal cytochrome P450 enzymes, making it valuable in developing drugs that inhibit ergosterol biosynthesis, a critical component of fungal cell membranes. Due to the chiral centers and specific stereochemistry, it enhances the selectivity and potency of the final drug product. Commonly employed in the manufacture of systemic antifungals for treating infections such as candidiasis and aspergillosis. Its application is mostly confined to research and development in pharmaceutical labs and large-scale drug synthesis.